Rory B. Riggs, Director at Royalty Pharma plc (RPRX), sold 273,650 shares at $45.26 ($12.4M) on 2021-06-07, disclosed to the SEC on 2021-06-08.
Scheduled sale ($12.4M) by Director.
Nothing distinguishes this filing.
| Filing → |
| CBUS | BUY | 2023-12-14 | $10.9M | — | Filing → |
| CBUS | BUY | 2023-06-02 | $32K | — | Filing → |
| RPRX | SELL | 2023-05-22 | $57.4M | — | Filing → |